|
Index | - | P/E | - | EPS (ttm) | -1.09 | Insider Own | 4.70% | Shs Outstand | 4.05M | Perf Week | -5.70% |
Market Cap | 25.06M | Forward P/E | - | EPS next Y | - | Insider Trans | 0.00% | Shs Float | 2.86M | Perf Month | -26.38% |
Income | -3.70M | PEG | - | EPS next Q | - | Inst Own | 0.10% | Short Float | 10.32% | Perf Quarter | 4.80% |
Sales | 0.60M | P/S | 41.76 | EPS this Y | 10.30% | Inst Trans | - | Short Ratio | 1.41 | Perf Half Y | -13.51% |
Book/sh | 2.90 | P/B | 1.66 | EPS next Y | - | ROA | -46.20% | Target Price | - | Perf Year | -48.39% |
Cash/sh | 1.88 | P/C | 2.56 | EPS next 5Y | - | ROE | -48.90% | 52W Range | 3.98 - 15.64 | Perf YTD | -35.82% |
Dividend | - | P/FCF | - | EPS past 5Y | -0.60% | ROI | -163.40% | 52W High | -69.30% | Beta | 1.68 |
Dividend % | - | Quick Ratio | 27.10 | Sales past 5Y | 92.10% | Gross Margin | 74.80% | 52W Low | 20.75% | ATR | 0.40 |
Employees | 4 | Current Ratio | 27.40 | Sales Q/Q | 78.90% | Oper. Margin | - | RSI (14) | 34.36 | Volatility | 4.89% 7.87% |
Optionable | No | Debt/Eq | 0.00 | EPS Q/Q | 127.80% | Profit Margin | - | Rel Volume | 0.15 | Prev Close | 4.96 |
Shortable | Yes | LT Debt/Eq | 0.00 | Earnings | - | Payout | - | Avg Volume | 208.98K | Price | 4.80 |
Recom | 1.00 | SMA20 | -11.30% | SMA50 | -21.77% | SMA200 | -34.92% | Volume | 33,096 | Change | -3.23% |
![]() | ||||||||||||||||||||||||||||||||||||||
![]() | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
![]() | ||||||||||||||||||||||||||||||||||||||
Lexaria Bioscience Corp. operates in the drug delivery platform business. It develops and out-licenses its DehydraTECH technology for the delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing, and higher effectiveness in active molecule delivery. The company has licensed DehydraTECH to various companies operating in the nicotine, pharmaceutical, nutraceutical, and vitamin industries. Lexaria Bioscience Corp. was founded in 2004 and is headquartered in Kelowna, Canada. | ||||||||||||||||||||||||||||||||||||||
![]() | ||||||||||||||||||||||||||||||||||||||
![]() |
open in yahoo | open in reuters | open in marketwatch | open in google |
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite